Home NDC 0069-0342 Zirabev
Product NDC 0069-0342
11-digit product format 000690342
Labeler code 0069
Product ID 0069-0342_3135aec5-1b5d-4de4-9b73-bfeb7821b75d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name bevacizumab-bvzr
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Pfizer Laboratories Div Pfizer Inc
Application BLA761099
Marketing category BLA
Marketing start 2020-01-13
Substance BEVACIZUMAB
Active strength 400 mg/16mL
Pharmacologic classes Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Zirabev
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BEVACIZUMAB 400 mg/16mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2S9ZZM9Q9V Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2268039 Internal RxNorm lookup 2268044 Internal RxNorm lookup 2268047 Internal RxNorm lookup 2268048 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0069-0342-01 Zirabev 1 in 1 CARTON INJECTION, SOLUTION 1 12 0069-0342-01 Zirabev 16 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION 16 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0069-0342 ZIRABEV (BEVACIZUMAB-BVZR) INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] 11 Current NDC, Legacy NDC, 2 package rows 20250124_aa27acbd-d117-4350-aeee-17bc2e2c0ca4.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Zirabev BEVACIZUMAB-BVZR Pfizer Laboratories Div Pfizer Inc aa27acbd-d117-4350-aeee-17bc2e2c0ca4 2026-07-21 Warnings, Adverse reactions Exact identifier application number: BLA761099 ndc (product): 0069-0342
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761099 Zirabev bevacizumab-bvzr 351(k) Biosimilar Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0069-0342-01 00069034201 1 VIAL, SINGLE-USE in 1 CARTON (0069-0342-01) / 16 mL in 1 VIAL, SINGLE-USE 2020-01-13 0000-00-00 No No Current